Funder: American Brain Tumor Association
Due Dates (Anticipated): December 2027 (LOI) | March 2028 (Full application)
Funding Amounts: $200,000 in direct costs over two years
Summary: Supports multi-institutional, multidisciplinary brain tumor research with potential to transform diagnosis or treatment.
Key Information: Lead PI and Co-PI must hold full-time faculty or institution-confirmed equivalent positions at distinct nonprofit, non-governmental institutions.
Description
The American Brain Tumor Association (ABTA) supports collaborative, high-risk/high-impact research with potential to change diagnostic or treatment paradigms for adult and pediatric brain tumor care. Research Collaboration Grants promote team science and help investigators conduct early scientific studies needed to secure future funding. Projects should combine disciplines such as basic, translational, clinical, and epidemiological research. Investigators outside traditional biological sciences are encouraged to apply.
The program covers all brain tumor types: benign or malignant, primary or secondary (metastatic), affecting pediatric or adult populations. Research areas include biomarkers, brain tumor biology, clinical research, diagnosis, drug delivery, etiology, genetics, imaging, molecular/genetic epidemiology, novel therapeutics, and risk assessment. Projects not directly related to brain tumor research are administratively withdrawn.
